Lynne Georgopoulos is the Sr. VP of Clinical Development and Regulatory Affairs for KinderPharm. Lynne is responsible for providing professional leadership to the organization to ensure compliance with all applicable Food and Drug Administration (FDA), European Medicines Agency (EMA) and International Conference on Harmonization (ICH) regulations from a pediatric perspective, as well as the creation and execution of preclinical, clinical and regulatory strategies to support the pediatric product pipeline of our clients. Lynne is an innovative, results-oriented, entrepreneurial-spirited biopharmaceutical executive with 25 years of experience in clinical operations/development, regulatory affairs, project management, and quality assurance. Lynne is a strong contributor to the leadership and team building of KinderPharm. Lynne manages the Clinical and Regulatory departments of KinderPharm as well as cross-functional groups, both internally and externally to meet aggressive development timelines. Lynne received a Master of Science in Health Sciences (MSHS) in Regulatory Affairs from The George Washington University and is regulatory affairs certified through the Regulatory Affairs Professional Society.